TaurusTrio TAVR System
Aortic Regurgitation
Pre-market (NMPA approved 2025)Recently launched
Key Facts
Indication
Aortic Regurgitation
Phase
Pre-market (NMPA approved 2025)
Status
Recently launched
Company
About Peijia Medical
A leading Chinese medtech company developing innovative transcatheter heart valve and neurointerventional devices for structural heart disease and stroke.
View full company profile